Does Rallies show Form 4 insider transactions for FHTX?

Yes. Rallies tracks FHTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is FHTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for FHTX. It does not provide personalized investment advice.

FHTX (Foghorn Therapeutics Inc. Common Stock) Stock Analysis - Insider Trades

Foghorn Therapeutics Inc. Common Stock (FHTX) is a publicly traded Healthcare sector company. As of May 21, 2026, FHTX trades at $4.01 with a market cap of $224.29M and a P/E ratio of -3.34. FHTX moved +11.25% today. Year to date, FHTX is -19.68%; over the trailing twelve months it is -3.38%. Its 52-week range spans $2.94 to $9.99. Analyst consensus is strong buy with an average price target of $11.60. Rallies surfaces FHTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading FHTX stock inside the company?

Recent FHTX insider activity includes Costa Carlos sold 857, Costa Carlos sold 35.76K, Costa Carlos sold 11.57K, Costa Carlos sold 10.27K, and Costa Carlos sold 400. Rallies tracks insider transaction dates, shares, prices, and estimated values.

FHTX Key Metrics

Key financial metrics for FHTX
Metric	Value
Price	$4.01
Market Cap	$224.29M
P/E Ratio	-3.34
EPS	$-1.16
Dividend Yield	0.00%
52-Week High	$9.99
52-Week Low	$2.94
Volume	226.79K
Avg Volume	0
Revenue (TTM)	$28.22M
Net Income	$-75.32M
Gross Margin	0.00%

Recent FHTX Insider Trades

Costa Carlos sold 857 (~$8.72K) on Sep 23, 2024.
Costa Carlos sold 35.76K (~$358.99K) on Sep 20, 2024.
Costa Carlos sold 11.57K (~$116.32K) on Sep 18, 2024.
Costa Carlos sold 10.27K (~$103.13K) on Sep 17, 2024.
Costa Carlos sold 400 (~$4.00K) on Sep 16, 2024.

Latest FHTX News

Foghorn Raises $50M, Extends Runway to 2028 and Advances FHD-909 Trial — Mar 11, 2026
Foghorn Therapeutics Appoints CFO Ryan Maynard, Bringing $1B Funding Track Record — Feb 23, 2026
Foghorn Therapeutics Secures $50M Registered Direct Financing at 30% Premium — Jan 14, 2026

FHTX Analyst Consensus

6 analysts cover FHTX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.60.

Common questions about FHTX

Who is trading FHTX stock inside the company?: Recent FHTX insider activity includes Costa Carlos sold 857, Costa Carlos sold 35.76K, Costa Carlos sold 11.57K, Costa Carlos sold 10.27K, and Costa Carlos sold 400. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for FHTX?: Yes. Rallies tracks FHTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is FHTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for FHTX. It does not provide personalized investment advice.